Pharmafile Logo
Pharmafocus logo
Advanced Search
pfizer_logo

Pfizer’s Xeljanz denied plaque psoriasis indication by FDA

October 16, 2015
Research and Development, Sales and Marketing FDA, Pfizer, Xeljanj, tofacitinib

The FDA has rejected the indication expansion of Pfizer’s Xeljanz (tofacitinib) for treatment of moderate to severe cases of plaque psoriasis. …

News
abbvies_humira_cost_the_most_to_market_in_the_us_last_month

Top 10 US pharma advertising spenders, September 2015

October 16, 2015
Medical Communications, Sales and Marketing

 As a new study from TV advertising metrics company iSpot reveals the top 40 pharma companies spent $231 million on TV …

Feature

NICE to recommend three new treatments for hep C

October 16, 2015
Medical Communications AbbVie, BMS, Bristol-Myers Squibb, Exviera, Gilead, NICE, Viekirax, daklinza, harvoni, hepatitis C

NICE has recommended Bristol-Myers Squibb’s Daklinza, Gilead’s Harvoni and AbbVie’s Viekirax, with or without Exviera, as treatments for some adults …

News
david_tweedale_and_ian_robinson

Ashfield UK makes two new business development appointments for its growing team

October 16, 2015
Medical Communications Ashfield UK

Ashfield has appointed David Tweedale and Ian Robinson as Business Development Managers to the UK Commercial and Clinical business, located …

Appointment
david_mustalish

The Prime Medical Group expands senior team in New York City

October 16, 2015
Medical Communications

The Prime Medical Group is pleased to announce several key appointments to its New York office as the company continues …

Appointment
texting mobile

Health apps now more popular than ever in the UK

October 16, 2015
Medical Communications apps, digital pharma, health technology, technology

The use of health apps has considerably increased over the past years, according to a new survey that has found …

News
NHS sign

NICE requests more evidence on Duchenne muscular dystrophy therapy

October 16, 2015
Medical Communications, Sales and Marketing Duchenne Muscular Dystrophy, NICE, PCT Therapeutics, Translarna, ataluren

NICE has chosen not to recommend has PTC Therapeutics’ treatment Translarna for Duchenne muscular dystrophy (DMD), asking for further clarification …

News

The Prime Medical Group expands senior team in New York City

October 15, 2015
Medical Communications The Prime Medical Group

The Prime Medical Group is pleased to announce several key appointments to its New York office as the company continues …

News
Press release
Valeant logo

Valeant receives court writ over US drug pricing

October 15, 2015
Medical Communications, Sales and Marketing Drug pricing, Isuprel, Nitropress, US, Valeant, subpoena

Valeant Pharmaceuticals has disclosed that it has received two subpoenas in the US, demanding evidence concerning the pricing and distribution …

News
T-cell

$350m collaboration deal for BMS and Five Prime Therapeutics

October 15, 2015
Research and Development BMS, Bristol-Myers Squibb, R&D, five prime, immuno-oncology, tumours

Bristol-Myers Squibb has signed a collaboration agreement with the US biotech firm Five Prime Therapeutics, for a Colony Stimulating Factor …

News
Ablynx flags

Ablynx and Merck begin immuno-oncology collaboration

October 15, 2015
Research and Development Ablynx, Merck, immuno-oncology, nanobody, proof of concept

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …

News
allergan_ceo_bernie_saunders

Allergan axes 117 jobs in Kythera buyout

October 15, 2015
Allergan, Kythera

According to a notice filed with the state of California, Allergan will be laying off 117 employees at Kythera’s Westlake …

Appointment
PM David Cameron

ABPI hits back at Prime Minister’s criticism of high drug prices

October 15, 2015
Sales and Marketing ABPI, Drug pricing, Duchenne Muscular Dystrophy, NICE, Translarna, ataluren, david cameron, prime minister, rare disease

The ABPI has responded to comments made by UK Prime Minister David Cameron during yesterday’s Prime Minster’s Questions, in which …

News

Crescendo Biologics appoints Dr Peter Pack as chief exec

October 15, 2015
Business Services, Research and Development

Crescendo Biologics has announced the appointment of Dr Peter Pack as chief executive, who will oversee the company’s new drug …

Appointment
WHO flag

Novartis and Biogen launch drug access programmes in developing countries

October 15, 2015
Manufacturing and Production, Sales and Marketing Biogen, Novartis, access, aid, corporate social responsibility, csr, humanitarian aid

Novartis and Biogen have begun new campaigns aimed at increasing access to medicines in developing countries.  The Swiss firm has …

News
MSD logo

Merck and Incyte to initiate Keytruda, epacadostat combo trial

October 15, 2015
Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …

News
Hilary Clinton

Hilary Clinton’s pharma ‘enemies’ amongst her biggest financial supporters

October 14, 2015
Drug pricing, Hilary Clinton, US, pricing reform

Hilary Clinton’s plans to make waging war with pharma companies a central plank of her US presidential campaign have been …

News
vrvb9xyi

Turing faces antitrust probe over Daraprim price hike

October 14, 2015
Sales and Marketing Daraprim, Turing Pharmaceuticals, turing

Turing Pharmaceuticals, the drug company that increased the price of the generic drug Daraprim 50-fold overnight, is facing an antitrust …

News
ebola_virus

Johnson & Johnson begins Ebola vaccine trial in Sierra Leone

October 14, 2015
Research and Development Ebola vaccine, Johnson & Johnson

Johnson & Johnson has begun a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen …

News
AstraZeneca plaque

AstraZeneca accused of tax avoidance in Dutch scheme

October 14, 2015
AstraZeneca, finance, tax, tax avoidance

AstraZeneca is the latest international firm to be accused of corporation tax avoidance, after an investigation claimed the firm is …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026